BIONTECH SE-ADR (BNTX)
US09075V1026 - ADR
BIONTECH SE-ADR
NASDAQ:BNTX (1/13/2025, 8:05:21 PM)
Premarket: 115.92 +2.18 (+1.92%)113.74
-9.11 (-7.42%)
Company Profile
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. The company is headquartered in Mainz, Rheinland-Pfalz and currently employs 6,133 full-time employees. The company went IPO on 2019-10-10. The firm focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The firm is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. The company also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules. In addition, the Company offers diagnostic products and drug discovery services for other therapeutic areas, including infectious diseases, allergies and autoimmune disorders.
Company Info
BIONTECH SE-ADR
An der Goldgrube 12
Mainz RHEINLAND-PFALZ 55131
P: 4949613190840
CEO: Ugur Sahin
Employees: 6133
Website: https://www.biontech.com/
BNTX News
5 days ago - Investor's Business DailyBiotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.Biotech stocks have seen three years of sideways to down trading. But obesity drugs, AI and Trump 2.0 promise to shake things up.
7 days ago - Investor's Business DailyModerna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid SpikeModerna, BioNTech and Novavax stocks popped after the CDC noted a recent increase in positive Covid tests.
10 days ago - The Motley Fool5 Predictions for the Stock Market in 2025 -- and Which Stocks Will Soar the Most If They're Righta month ago - Investor's Business DailyPfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, KennedyPfizer stock is setting up for a wild ride in 2025 as it faces off with an activist and, possibly, Robert F. Kennedy Jr. at HHS.
a month ago - The Motley Fool3 No-Brainer Biotech Stocks to Buy With $200 Right Nowa month ago - Yahoo Finance3 No-Brainer Biotech Stocks to Buy With $200 Right NowHere are three no-brainer biotech stocks to buy with $200 right now. Biotech stocks usually appeal more to aggressive growth investors, while value investors typically prefer to look elsewhere. You can scoop up a share of BioNTech for less than $120 at the time of this writing.
BNTX Twits
Here you can normally see the latest stock twits on BNTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
